InvestorsHub Logo
icon url

3xBuBu

03/10/11 12:26 PM

#65483 RE: langlui #65475

HGSI Apr 2011 32.000 call
(HGSI110416C00032000)@0.76
HGSI, FDA approved the company's experimental lupus drug. Benlysta, which was developed in concert with GlaxoSmithKline (GSK), is expected to be available to patients "within about two weeks," according to a joint statement. The freshly approved drug is the first new treatment for systemic lupus in more than 50 years.

icon url

3xBuBu

03/10/11 12:26 PM

#65484 RE: langlui #65475

QQQQ trading sideway since open,
could recoupe some losses at EOD